238 related articles for article (PubMed ID: 21168678)
41. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Wolczynski S; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3466-9. PubMed ID: 19100414
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
White SL; Polkinghorne KR; Atkins RC; Chadban SJ
Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
[TBL] [Abstract][Full Text] [Related]
43. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
[TBL] [Abstract][Full Text] [Related]
44. Chronic kidney disease stage in renal transplantation classification using cystatin C and creatinine-based equations.
White C; Akbari A; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
Nephrol Dial Transplant; 2007 Oct; 22(10):3013-20. PubMed ID: 17556417
[TBL] [Abstract][Full Text] [Related]
45. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
46. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods.
White C; Akbari A; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
J Am Soc Nephrol; 2005 Dec; 16(12):3763-70. PubMed ID: 16236805
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
49. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
50. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.
Boudville N; Salama M; Jeffrey GP; Ferrari P
Nephrol Dial Transplant; 2009 Sep; 24(9):2926-30. PubMed ID: 19506046
[TBL] [Abstract][Full Text] [Related]
51. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
52. Effect of GFR on plasma N-terminal connective tissue growth factor (CTGF) concentrations.
Gerritsen KG; Abrahams AC; Peters HP; Nguyen TQ; Koeners MP; den Hoedt CH; Dendooven A; van den Dorpel MA; Blankestijn PJ; Wetzels JF; Joles JA; Goldschmeding R; Kok RJ
Am J Kidney Dis; 2012 May; 59(5):619-27. PubMed ID: 22342213
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the equations to estimate the glomerular filtration rate in kidney transplant recipients.
Estrada-Zambrano A; Biosca-Adzet C; Bayés-Genís B; Doladé-Botias M; Lauzurica-Valdemoros R; Romero-González R
Transplant Proc; 2007 Sep; 39(7):2210-3. PubMed ID: 17889140
[TBL] [Abstract][Full Text] [Related]
54. Copeptin Blood Content as a Diagnostic Marker of Chronic Kidney Disease.
Niemczyk S; Niemczyk L; Żmudzki W; Saracyn M; Czarzasta K; Szamotulska K; Cudnoch-Jędrzejewska A
Adv Exp Med Biol; 2018; 1096():83-91. PubMed ID: 29572679
[TBL] [Abstract][Full Text] [Related]
55. Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: An analysis of the UNOS database.
Habib PJ; Patel PC; Hodge D; Chimato N; Yip DS; Hosenpud JD; Wadei HM
J Heart Lung Transplant; 2016 Dec; 35(12):1471-1479. PubMed ID: 27425400
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic performance of serum cystatin C and serum creatinine in the prediction of chronic kidney disease in renal transplant recipients.
Tsai JP; Wu SW; Hung TW; Kao WT; Hong CL; Lian JD; Chang HR
Transplant Proc; 2010 Dec; 42(10):4530-3. PubMed ID: 21168730
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of iron deficiency in heart and kidney allograft recipients.
Przybylowski P; Malyszko J; Glowinska I; Malyszko J; Kozlowska S; Mysliwiec M
Transplant Proc; 2011 Dec; 43(10):3885-7. PubMed ID: 22172865
[TBL] [Abstract][Full Text] [Related]
58. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
59. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes.
Van Biesen W; Vanholder R; Veys N; Verbeke F; Delanghe J; De Bacquer D; Lameire N
Nephrol Dial Transplant; 2006 Jan; 21(1):77-83. PubMed ID: 16221704
[TBL] [Abstract][Full Text] [Related]
60. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
Boertien WE; Meijer E; Zittema D; van Dijk MA; Rabelink TJ; Breuning MH; Struck J; Bakker SJ; Peters DJ; de Jong PE; Gansevoort RT
Nephrol Dial Transplant; 2012 Nov; 27(11):4131-7. PubMed ID: 22523115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
